title: Cancer stem cells in haematological malignancies.
abstract: At least several types of human haematological malignancies can now be seen as 'stem-cell diseases'. The best-studied in this context is acute myeloid leukaemia (AML). It has been shown that these diseases are driven by a pool of 'leukaemia stem cells (LSC)', which remain in the quiescent state, have the capacity to survive and self-renew, and are responsible for the recurrence of cancer after classical chemotherapy. It has been understood that LSC must be eliminated in order to cure patients suffering from haematological cancers. Recent advances in LSC research have allowed for description of LSC phenotype and identification of potential targets for anti-LSC therapies. This concise review summarises the current view on LSC biology and targeted approaches against LSC.
authors.affiliation: Department of Immunology, Centre of Biostructure Research, Medical University of Warsaw, Poland.
authors.forename: Radoslaw
authors.initials: R
authors.lastname: Zagozdzon
authors.affiliation: Department of Immunology, Centre of Biostructure Research, Medical University of Warsaw, Poland.
authors.forename: Jakub
authors.initials: J
authors.lastname: Golab
keywords: cancer recurrence; chemotherapy resistance; leukaemia stem cell; self-renewal; targeted therapies